Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older

Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older

Introduction and Objectives: Clinical data for older patients with advanced liver disease are limited. This post hoc analysis evaluated the efficacy and safety of terlipressin in patients aged ≥65 years with hepatorenal syndrome using data from 3 Phase III, randomized, placebo-controlled studies (OT...

Full description

Bibliographic Details
Main Authors: Muhammad A. Mujtaba, Ann Kathleen Gamilla-Crudo, Shehzad N. Merwat, Syed A. Hussain, Michael Kueht, Aftab Karim, Muhammad W. Khattak, Peggy J. Rooney, Khurram Jamil
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Annals of Hepatology
Subjects:
Acute renal failure
Cirrhosis
Geriatrics
Hepatorenal syndrome
Renal replacement therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268123002302

Internet

http://www.sciencedirect.com/science/article/pii/S1665268123002302

Similar Items